Antibody-Drug Conjugates Used in Breast Cancers.

J Oncol

Faculty of Medicine, Damascus University, Damascus, Syria.

Published: June 2021

The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257388PMC
http://dx.doi.org/10.1155/2021/9927433DOI Listing

Publication Analysis

Top Keywords

antibody-drug conjugates
8
breast cancer
8
conjugates breast
4
breast cancers
4
cancers prognosis
4
prognosis breast
4
cancer radically
4
radically changed
4
changed years
4
years continues
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!